rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Centene Corporation

CNC · NYSE

Health CareManaged Care & InsurersLeading

CNC stood above a rising 150-day average in 29 of the last 52 weekly readings, including each of the last 26 weeks. It is 18.0% above that average now. Managed Care & Insurers: 70% of its 10 stocks in an uptrend (±0 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
26 in a row
Industry in uptrend
70% 0 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$26.7M
Officials’ trades on record
70

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 29 of 52 weeks.

20 Apr – 19 Oct
13%50%87%Apr 26Jun 26Jul 26Sep 26Oct 26

Managed Care & Insurers: Most of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$13.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

70 disclosed lines: House 68, Senate 0, executive 2; 19 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k11 May 2026filed 1 Jul 2026
Tim Moore House: U.S. House ClerkNC14sold$100k–$250k18 Aug 2025filed 3 Sep 2025
Julia Letlow House: U.S. House ClerkLA05sold$1k–$15k8 Aug 2025filed 13 Jan 2026
Tim Moore House: U.S. House ClerkNC14bought$1k–$15k8 Aug 2025filed 3 Sep 2025
Tim Moore House: U.S. House ClerkNC14bought$15k–$50k7 Aug 2025filed 3 Sep 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k5 Aug 2025filed 12 Sep 2025
Tim Moore House: U.S. House ClerkNC14bought$15k–$50k30 Jul 2025filed 5 Aug 2025
Tim Moore House: U.S. House ClerkNC14bought$15k–$50k29 Jul 2025filed 5 Aug 2025
Tim Moore House: U.S. House ClerkNC14bought$1k–$15k22 Jul 2025filed 5 Aug 2025
Tim Moore House: U.S. House ClerkNC14bought$15k–$50k21 Jul 2025filed 5 Aug 2025
Tim Moore House: U.S. House ClerkNC14bought$15k–$50k18 Jul 2025filed 5 Aug 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months5
Buyers · sellers0 · 2
WhoDidSharesTraded
Christopher KosterSecretary & General Counselsold56,500at $66.9026 Aug 2026filed 27 Aug 2026
Christopher KosterSecretary & General Counselsold47,603at $65.3618 Aug 2026filed 19 Aug 2026
Kenneth A. BurdickDirectorsold80,000at $64.5510 Jun 2026filed 11 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Michael A. Carson Company insiderGroup President, Medicare&Spec · last 15 Oct 20260 · 0
Christopher J. Coughlin Company insiderDirector · last 30 Sep 20262 · 1
Frederick H. Eppinger Company insiderDirector · last 30 Sep 20260 · 1
Kenneth Tanji Company insiderDirector · last 30 Sep 20260 · 0
Lauren M. Tyler Company insiderDirector · last 30 Sep 20260 · 0
Theodore R. Samuels II Company insiderDirector · last 30 Sep 20264 · 0
Theodore J. Pienkos Company insiderCorporate Controller & CAO · last 15 Sep 20260 · 0
Christopher Koster Company insiderSecretary & General Counsel · last 26 Aug 20260 · 3
Paul J. Diaz Company insiderDirector · last 28 Jul 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 8 Jul 20262 · 0
Susan Raye Smith Company insiderChief Operating Officer · last 15 Jun 20260 · 0
Kenneth A. Burdick Company insiderDirector · last 10 Jun 20260 · 13

Same industry

HUM HumanaLeading+25%
MOH Molina HealthcareJust started moving+10%
UNH UnitedHealth GroupJust started moving+8%
TRUP TrupanionAbove a falling average+7%
CI The Cigna GroupAbove a falling average+6%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 20257.3%
Operating profit marginFY 2025 · to 31 Dec 2025-3.9%
Free cash flow marginFY 2025 · to 31 Dec 20252.2%
Return on capital employedFY 2025 · to 31 Dec 2025-19.0%
Debt to equityFY 2025 · to 31 Dec 20250.88×
Share count trendFY 2025 · to 13 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$17.9B
Free cash flowFY 2025 · to 31 Dec 2025$4.3B

Analyst forecasts

No analyst forecasts yet.